Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
Contact Us |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages
Start Over | Back to Previous Screen
Furosemide Injection
Status: Currently in Shortage
»Date first posted:
04/07/2020
»Therapeutic Categories: Cardiovascular
Accord Healthcare Inc. (New 03/27/2023)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
10 mg/ml (SDV) USP; 20 mg/2 ml; 25 pk [2 ml] Vial (NDC 16729-500-08) | Unavailable | Inventory on hold pending further assessment. | Other |
10 mg/ml (SDV) USP; 40 mg/4 ml; 10 pk [4 ml] Vial (NDC 16729-501-43) | Unavailable | Inventory on hold pending further assessment. | Other |
10 mg/ml (SDV) USP; 100 mg/10 ml; 10 pk [10 ml] Vial (NDC 16729-502-43) | Unavailable | Inventory on hold pending further assessment. | Other |
Athenex Pharmaceutical Division, LLC (Athenex) (Reverified 03/24/2023)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
20 mg/2mL vial (NDC 70860-302-41 and 70860-302-02) | Available | ||
40 mg/4mL vial (NDC 70860-302-42 and 70860-302-04) | Available | ||
100 mg/10mL vial (NDC 70860-302-43 and 70860-302-10) | Available |
Avet Pharmaceuticals Inc (Revised 10/31/2022)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
20 mg/mL (NDC 23155-473-41) | Available | ||
40 mg/4mL (NDC 23155-473-42) | Available | ||
100 mg/10mL (NDC 23155-473-44) | Available |
Baxter Healthcare (Reverified 03/29/2023)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Furosemide Injection, USP, 10 mg/mL - 10 mL Single Dose Glass Vial (25 x 10 mL) (NDC 36000-284-25) | Available | ||
Furosemide Injection, USP, 10 mg/mL - 2 mL Single Dose Glass Vial (25 x 2 mL)(NDC 36000-282-25) | Available | ||
Furosemide Injection, USP, 10 mg/mL - 4 mL Single Dose Glass Vial (25 x 4 mL)(NDC 36000-283-25) | Available |
Eugia Pharma Specialties LTD. (formerly Aurobindo) (Reverified 03/17/2023)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
20 mg/2 mL single-dose vial (NDC 55150-322-25) | Currently on backorder - next shipment TBD | Delay in shipping of the drug | |
40 mg/4 mL single-dose vial (NDC 55150-323-25) | Currently on backorder, next shipment TBD | Delay in shipping of the drug | |
100 mg/10 mL single-dose vial (NDC 55150-324-25) | Currently on backorder, next shipment TBD | Delay in shipping of the drug |
Fresenius Kabi USA, LLC (Revised 03/31/2023)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
20 mg per 2 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-02) | Available | Check wholesalers for inventory. | Demand increase for the drug |
40 mg per 4 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-04) | Backordered. Next release April 2023. | Demand increase for the drug | |
100 mg per 10 mL (10 mg per mL), Amber, single dose vial (NDC 63323-280-10) | Available | Check wholesalers for inventory. | Demand increase for the drug |
Gland Pharma Limited (Reverified 07/01/2022)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
2 mL in 1 vial, 25 vials/carton (NDC 25021-311-02) | Available | Demand increase for the drug | |
4 mL in 1 vial, 25 vials/carton (NDC 25021-311-04) | Available | Demand increase for the drug | |
10 mL in 1 vial, 25 vials/carton (NDC 25021-311-10) | Available | Demand increase for the drug |
Hospira, Inc., a Pfizer company (Revised 03/31/2023)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
20 mg/2 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-6102-02) | Available | Other | |
40 mg/4 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-6102-04) | Limited Supply Available. Next Delivery: April 2023; Estimated Recovery: June 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
100 mg/10 mL (10 mg/mL): Single Dose Glass Fliptop Vial (NDC 0409-6102-10) | Limited Supply Available. Next Delivery: May 2023; Estimated Recovery: June 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
20 mg/2 mL (10 mg/mL); Single Dose Glass Fliptop Vial NovaPlus (NDC 0409-6102-25) | Available | Other | |
40 mg/4 mL (10 mg/mL); Single Dose Glass Fliptop Vial NovaPlus (NDC 0409-6102-26) | Available | Other | |
100 mg/10 mL (10 mg/mL): Single Dose Glass Fliptop Vial NovaPlus (NDC 0409-6102-27) | Next Delivery: April 2023; Estimated Recovery: June 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
Meitheal Pharmaceuticals, Inc. (Reverified 02/13/2023)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
20 mg per 2 mL (NDC 71288-205-03) | Available | ||
40 mg per 4 mL (NDC 71288-203-05) | Available | ||
100 mg per 10 mL (NDC 71288-203-11) | Available |
Sagent Pharmaceuticals (Reverified 03/22/2023)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
20 mg/2 mL single-dose vial (NDC 25021-311-02) | Available. | ||
40 mg/4 mL single-dose vial (NDC25021-311-04) | Available. | ||
100 mg/10 mL single-dose vial (NDC 25021-311-10) | Available |